Abstract
A deletion variant in the CHEK2 gene (del1100C) has been implicated as a low-penetrance risk factor for breast cancer. We sought to determine contribution of CHEK2 mutations to the etiology of ovarian cancer (OvCa). We used cases ascertained from the United States through Gynecologic Oncology Group (GOG) protocols 172, 182, and 144, the University of Hawaii Cancer Research Center, and Creighton University. Control women were recruited from Pittsburgh and Hawaii. Denaturing high-performance liquid chromatography, sequence analysis, and single nucleotide polymorphism genotyping by Pyrosequencing were employed to analyze the CHEK2 gene. Mutation screening of the CHEK2 gene in 48 cases who had a first-degree relative with OvCa uncovered only del1100C and A252G variants. Altogether, the del1100C variant was detected in none of 751 unselected cases, in 1 of 52 (1.9%) cases who had a first-degree relative with OvCa, and in 3 of 521 (0.6%) unselected controls. The frequencies of del1100C and A252G variants did not show statistically significant differences between the cases and the controls. These results suggest that variations in CHEK2 do not make a significant contribution to the pathogenesis of OvCa in the U.S. population.
References
Oct 7, 1994·Science·Y MikiW Ding
Dec 21, 1995·Nature·R WoosterG Micklem
Mar 14, 1996·Nature·C DibJ Weissenbach
Sep 13, 1996·Science·N Risch, K Merikangas
May 14, 1998·American Journal of Obstetrics and Gynecology·S C RubinJ Boyd
Aug 27, 1998·American Journal of Human Genetics·K W BromanJ L Weber
Apr 10, 1999·Human Molecular Genetics·S A JanezicH Anton-Culver
Sep 16, 1999·American Journal of Human Genetics·S A GaytherB A Ponder
Mar 15, 2001·Leukemia Research·W K HofmannH P Koeffler
Mar 22, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R J Edmondson, J M Monaghan
Apr 13, 2002·Blood·Akira HangaishiHisamaru Hirai
Apr 23, 2002·Nature Genetics·Hanne Meijers-HeijboerUNKNOWN CHEK2-Breast Cancer Consortium
Jul 3, 2002·American Journal of Human Genetics·Pia VahteristoHeli Nevanlinna
Jul 12, 2002·Nature·Elisabeth DawsonIan Dunham
Jul 12, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Clare H McGowan
Sep 19, 2002·Journal of the National Cancer Institute·Jeffrey L HiltonRichard E Buller
Jan 21, 2003·American Journal of Human Genetics·Xiangyang DongWanguo Liu
Mar 1, 2003·American Journal of Human Genetics·Mieke SchutteUNKNOWN Breast Cancer Linkage Consortium
Apr 12, 2003·American Journal of Human Genetics·Hanne Meijers-HeijboerMieke Schutte
Oct 22, 2003·Cancer Letters·Lara LiptonRichard S Houlston
Oct 22, 2003·Journal of Medical Genetics·O KilpivaaraH Nevanlinna
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Ana OsorioJavier Benítez
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Michael R DufaultNorbert Arnold
Citations
Dec 14, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deborah ThompsonDouglas F Easton
Apr 3, 2009·Hereditary Cancer in Clinical Practice·Evgeny N SuspitsinEvgeny N Imyanitov
Jan 1, 2007·Hereditary Cancer in Clinical Practice·Nadezhda Yu KrylovaEvgeny N Imyanitov
Sep 26, 2006·Oncogene·H Nevanlinna, J Bartek
Dec 16, 2006·Leukemia & Lymphoma·Gabrielle S SellickRichard S Houlston
Jan 28, 2015·Gynecologic Oncology·Lindsey E MinionBradley J Monk
Nov 25, 2011·Gynecologic Oncology·Chunqiao TianJulie A DeLoia
Apr 19, 2011·Gynecologic Oncology·Thomas C KrivakJulie A Deloia
Mar 18, 2010·Gynecologic Oncology·Kathleen M Darcy, Michael J Birrer
Oct 22, 2008·Seminars in Oncology·George A Omura, UNKNOWN Gynecologic Oncology Group
Dec 19, 2006·Mutation Research·El Mustapha BahassiPeter J Stambrook
May 28, 2011·Human Mutation·Yin LiuYuntao Xie
Jan 27, 2015·Oncogene·N WangY Wang
Jun 7, 2011·Biochimica Et Biophysica Acta·M G M BraemN C Onland-Moret
Jun 16, 2015·BioMed Research International·Angela TossLaura Cortesi
Jun 1, 2014·Cell Cycle·Ghim Siong OwVladimir A Kuznetsov
Jun 15, 2016·Nature Reviews. Clinical Oncology·Nadine TungMark E Robson
Dec 13, 2005·Cancer Genetics and Cytogenetics·Ans BaeyensAnne Vral
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas C KrivakUNKNOWN Gynecologic Oncology Group Phase III Trial
May 18, 2019·Clinical Genetics·Nicola FlaumDafydd G Evans
Aug 10, 2019·PloS One·Nutan V BadgujarFranky D Shah
Jan 18, 2019·Journal of Human Genetics·Ana KrivokucaMirjana Brankovic-Magic
Feb 13, 2020·International Journal of Molecular Sciences·Davide AngeliGianluca Tedaldi
May 6, 2019·International Journal of Cancer. Journal International Du Cancer·Petra KleiblovaZdenek Kleibl
Feb 7, 2020·NPJ Genomic Medicine·Fawz S AlHarthiMalak Abedalthagafi
Feb 3, 2021·NPJ Genomic Medicine·Fawz S AlHarthiMalak Abedalthagafi
Jul 3, 2021·Biomedicines·Mihaela Raluca RaduViorica Elena Rădoi